NCT05828836 is a Phase 2, PHASE3 clinical trial of Allopurinol Tablet in Cirrhosis, Liver, sponsored by Tanta University.

Who is sponsoring NCT05828836?

NCT05828836 is sponsored by Tanta University.

What drugs are being tested in NCT05828836?

Interventions in NCT05828836: Allopurinol Tablet, Placebo.

What condition does NCT05828836 study?

NCT05828836 studies Cirrhosis, Liver.

Is NCT05828836 still recruiting?

NCT05828836 is currently completed. Last updated 31 October 2023.

Last reviewed 2023-10-31 · How we verify

NCT05828836

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Allopurinol and Quality of Life in Liver Cirrhosis

Completed Phase 2, PHASE3 Last updated 31 October 2023

What this trial tests

Phase 2, PHASE3 trial testing Allopurinol Tablet in Cirrhosis, Liver in 100 participants. Completed in 1 March 2023.

Timeline

15 June 2022

Primary endpoint
15 January 2023

1 March 2023

Quick facts

Lead sponsor	Tanta University
Phase	Phase 2, PHASE3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	100
Start date	15 June 2022
Primary completion	15 January 2023
Estimated completion	1 March 2023
Sites	1 location across Egypt

Drugs / interventions tested

Allopurinol Tablet — full drug profile →
Placebo

Conditions studied

Cirrhosis, Liver — all drugs for Cirrhosis, Liver →

Sponsor

Tanta University

Who can join

Adults 18 to 70, any sex, with Cirrhosis, Liver. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate the impact of allopurinol on patients' related quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Allopurinol Tablet

Trials testing the same drug.

NCT07369622 — HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness · Phase 4 · not yet recruiting
NCT07033533 — Allopurinol and Pathogenesis of Cirrhosis · Phase 1, PHASE2 · completed
NCT05253833 — Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout · Phase 2 · completed
NCT04550234 — A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and Allopurinol · Phase 1 · completed

Other recruiting trials for Cirrhosis, Liver

Currently open trials in the same condition.

NCT07286643 — Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis · NA · recruiting
NCT06871111 — The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial · Phase 1 · recruiting
NCT07122700 — Evaluation of Non-Invasive Tests for Metabolic Liver Disease · recruiting
NCT07051369 — Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound · active not recruiting
NCT06908785 — Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM) · recruiting

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05828836 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 31 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05828836.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing